Keeping Current

Mar 31, 2023

Half of people with severe non-proliferative diabetic retinopathy will have proliferative disease within a year. What can be done?
  
Credit available for this activity expires: 03/31/2024
Earn Credit / Learning Objectives & Disclosures:

Mar 30, 2023

Did you know what the inherent variability of all biologics and what degree of variation are acceptable by regulatory bodies? 

Earn Credit / Learning Objectives & Disclosures:

Mar 29, 2023

What is the clinical use of biosimilars and how to best communicate with patients to avoid the nocebo effect? 

Credit available for this activity expires: 3/29/24
Earn Credit / Learning Objectives & Disclosures:

Mar 29, 2023

Do you reload when switching? What intervals do you extend by? How long is feasible between treatments, and how do you monitor? Learn from the experts.
  
Credit available for this activity expires: 28/03/2024
Earn Credit / Learning Objectives & Disclosures:

Mar 28, 2023

Do you know how study designs influence the data with anti-vascular endothelial growth factor (anti-VEGF) therapies? Find out more. 

Earn Credit / Learning Objectives & Disclosures: